A novel non-xanthine adenosine A 1 receptor antagonist

By Terai T.   Kita Y.   Kusunoki T.   Shimazaki T.   Ando T.   Horiai H.   Akahane A.   Shiokawa Y.   Yoshida K.  

European Journal of Pharmacology, Vol. 279, Iss. 2, 1995-06 ,pp. : 217-225

Elsevier

Access to resources Recommend Favorite

Novel therapy in Parkinson's disease: adenosine A_2A receptor antagonists

By Szabóó Nikoletta   Kincses Zsigmond Tamáás   Véécsei Láászlóó  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 4, 2011-04 ,pp. : 441-455

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of A₂ and A₃ adenosine receptor: a review of novel patented ligands

By Federico Stephanie   Spalluto Giampiero  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 4, 2012-04 ,pp. : 369-390

Informa Healthcare

Access to resources Recommend Favorite

Istradefylline, a novel adenosine A_2A receptor antagonist, for the treatment of Parkinson’s disease

By Jenner Peter  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 6, 2005-06 ,pp. : 729-738

Informa Healthcare

Access to resources Recommend Favorite

A novel glucocorticoid pharmacophore

By  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 1, 2000-01 ,pp. : 117-120

Informa Healthcare

Access to resources Recommend Favorite